India Globalization Capital PE Ratio 2006-2019 | IGC

Current and historical p/e ratio for India Globalization Capital (IGC) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. India Globalization Capital PE ratio as of November 14, 2019 is 0.00.
India Globalization Capital PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-11-14 0.79 0.00
2019-06-30 1.64 $-0.14 0.00
2019-03-31 2.08 $-0.13 0.00
2018-09-30 6.45 $-0.09 0.00
2018-06-30 0.49 $-0.07 0.00
2018-03-31 0.56 $-0.07 0.00
2017-12-31 1.00 $-0.08 0.00
2017-09-30 0.36 $-0.06 0.00
2017-06-30 0.41 $-0.07 0.00
2017-03-31 0.47 $-0.07 0.00
2016-12-31 0.28 $-0.12 0.00
2016-09-30 0.46 $-0.14 0.00
2016-06-30 0.52 $-0.16 0.00
2016-03-31 0.52 $-0.17 0.00
2015-12-31 0.24 $-0.19 0.00
2015-09-30 0.19 $-0.22 0.00
2015-06-30 0.40 $-0.25 0.00
2015-03-31 0.44 $-0.34 0.00
2014-12-31 0.67 $-0.41 0.00
2014-09-30 0.70 $-0.40 0.00
2014-06-30 1.42 $-0.42 0.00
2014-03-31 0.78 $-0.39 0.00
2013-12-31 1.04 $-0.53 0.00
2013-09-30 1.05 $-0.39 0.00
2013-06-30 1.60 $-0.30 0.00
2013-03-31 2.79 $-0.31 0.00
2012-12-31 1.35 $-1.00 0.00
2012-09-30 1.70 $-2.00 0.00
2012-06-30 2.31 $-2.40 0.00
2012-03-31 4.90 $-2.70 0.00
2011-12-31 2.89 $-12.80 0.00
2011-09-30 1.75 $-13.10 0.00
2011-06-30 3.80 $-13.30 0.00
2011-03-31 5.40 $-13.30 0.00
2010-12-31 5.75 $-0.80 0.00
2010-09-30 11.80 $-4.20 0.00
2010-06-30 9.20 $-4.10 0.00
2010-03-31 11.70 $-4.20 0.00
2009-12-31 13.80 $-5.70 0.00
2009-09-30 17.90 $-3.10 0.00
2009-06-30 11.50 $-2.50 0.00
2009-03-31 5.20 $-0.60 0.00
2008-12-31 9.70 $-6.60 0.00
2008-09-30 48.40 $-4.60 0.00
2008-06-30 50.00 $-4.70 0.00
2008-03-31 44.90 $-6.10 0.00
2007-12-31 59.00 0 0.00
2007-09-30 58.50 0 0.00
2007-06-30 57.40 0 0.00
2007-03-31 58.40 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.033B $0.005B
India Globalization Capital, Inc. is engaged in developing phytocannabinoid-based therapies. The company's patent filing for the indications of pain, medical refractory epilepsy and cachexia using phytocannabinoids. It also engage in leasing, trading, developing and managing infrastructure and real estate projects. India Globalization Capital, Inc. is based in Bethesda, Maryland.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.436B 9.87
Zoetis (ZTS) United States $55.465B 33.18
Astellas Pharma (ALPMY) Japan $32.512B 15.49
Eisai (ESALY) Japan $19.065B 36.76
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.989B 19.12
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.214B 482.22
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.106B 16.42
Jazz Pharmaceuticals (JAZZ) Ireland $7.542B 9.63
Sage Therapeutics (SAGE) United States $7.464B 0.00
Catalent (CTLT) United States $7.250B 29.49
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.241B 18.84
Arrowhead Pharmaceuticals (ARWR) United States $4.599B 105.46
United Therapeutics (UTHR) United States $3.883B 0.00
Nektar Therapeutics (NKTR) United States $3.508B 0.00
Evotec AG (EVTCY) Germany $3.119B 51.04
FibroGen (FGEN) United States $3.006B 88.67
Taro Pharmaceutical Industries (TARO) Israel $2.911B 10.64
PTC Therapeutics (PTCT) United States $2.650B 0.00
Portola Pharmaceuticals (PTLA) United States $2.130B 0.00
Tilray (TLRY) Canada $2.044B 0.00
Zogenix (ZGNX) United States $2.006B 0.00
Xencor (XNCR) United States $1.983B 60.28
Corcept Therapeutics (CORT) United States $1.872B 22.75
Heron Therapeutics (HRTX) United States $1.812B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.789B 52.93
Ironwood Pharmaceuticals (IRWD) United States $1.784B 56.88
USANA Health Sciences (USNA) United States $1.601B 17.09
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.220B 20.13
Radius Health (RDUS) United States $1.106B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.984B 0.00
Endo (ENDP) Ireland $0.973B 1.79
Karyopharm Therapeutics (KPTI) United States $0.948B 0.00
ArQule (ARQL) United States $0.937B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.932B 0.00
Aerie Pharmaceuticals (AERI) United States $0.871B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.823B 5.61
Organogenesis Holdings (ORGO) United States $0.767B 0.00
TherapeuticsMD (TXMD) United States $0.729B 0.00
Collegium Pharmaceutical (COLL) United States $0.612B 0.00
Flexion Therapeutics (FLXN) United States $0.612B 0.00
Translate Bio (TBIO) United States $0.559B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ChemoCentryx (CCXI) United States $0.534B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.504B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.468B 56.75
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.454B 0.00
Dermira (DERM) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.406B 9.28
OptiNose (OPTN) United States $0.400B 0.00
Akebia Therapeutics (AKBA) United States $0.393B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
DURECT (DRRX) United States $0.390B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.390B 16.79
Recro Pharma (REPH) United States $0.389B 0.00
Indivior (INVVY) United States $0.386B 1.40
Ardelyx (ARDX) United States $0.382B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.365B 4.24
Harpoon Therapeutics (HARP) United States $0.333B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.277B 0.00
GlycoMimetics (GLYC) United States $0.271B 0.00
Molecular Templates (MTEM) United States $0.265B 0.00
Rafael Holdings (RFL) United States $0.248B 0.00
Xeris Pharmaceuticals (XERS) United States $0.219B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
Jounce Therapeutics (JNCE) United States $0.186B 2.48
Calithera Biosciences (CALA) United States $0.185B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 31.40
Avadel Pharmaceuticals (AVDL) Ireland $0.179B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.177B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.171B 0.00
Concert Pharmaceuticals (CNCE) United States $0.165B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
CV Sciences (CVSI) United States $0.156B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.146B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
MEI Pharma (MEIP) United States $0.136B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.134B 0.00
Ocular Therapeutix (OCUL) United States $0.133B 0.00
IMV INC (IMV) Canada $0.125B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.095B 0.00
Majesco Entertainment (PTE) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Otonomy (OTIC) United States $0.077B 0.00
MediWound (MDWD) Israel $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 22.27
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.064B 9.70
Generex Biotechnology (GNBT) United States $0.061B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.058B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
Novan (NOVN) United States $0.058B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Genocea Biosciences (GNCA) United States $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Capnia (SLNO) United States $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.048B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Mast Therapeutics (SVRA) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.027B 0.00
IsoRay (ISR) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 17.07
Regulus Therapeutics (RGLS) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00